China’s Bank Lending Plummets in July Amid Weak Demand and Seasonal Factors
China’s bank lending dropped much more than expected in July due to weak credit demand and seasonal factors, despite the central bank promising to support the economy. Chinese banks issued 260 billion yuan ($36.26 billion) in new loans in July, which was almost 88% less than the previous month and also below analysts’ predictions. This […]


China’s bank lending dropped much more than expected in July due to weak credit demand and seasonal factors, despite the central bank promising to support the economy.
Chinese banks issued 260 billion yuan ($36.26 billion) in new loans in July, which was almost 88% less than the previous month and also below analysts’ predictions. This was a significant decrease from June’s 2.13 trillion yuan and also lower than the 345.9 billion yuan from the same month last year.
For the first seven months of this year, banks issued a total of 13.53 trillion yuan in new loans.
To boost the economy, the People’s Bank of China (PBOC) took action on July 25 by conducting a medium-term lending facility (MLF) operation and lowering interest rates. On the same day, five major state-owned banks reduced their deposit rates to mitigate the impact on their already low profit margins.
The growth of outstanding yuan loans slowed to 8.7% compared to a year earlier, down from 8.8% in June, and below the expected 8.8%.
The annual growth rate of total social financing (TSF), which measures overall credit and liquidity, increased to 8.2% from 8.1% in June. However, total social financing for July fell to 770 billion yuan, less than the forecast of 1.1 trillion yuan and a drop from 3.3 trillion yuan in June.
Related News

US Imposes Section 301 Tariffs on India, China, EU and 57 Other Economies

India Records 21% Rainfall Deficit as Monsoon Lags, Govt Rules Out Crop Impact

India’s Wind Power Capacity Hits 57,443 MW, Generation Surges in FY26

India’s Primary Energy Supply Rises to 39,055 PJ in FY25: MoSPI

Trump Unveils New US Tariff Plan for Generic Drug Imports from 2026

